Tag Archives: fondaparinux
September 2010 Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure
March 2006 Br J Cardiol 2006;13:90-8
American College of Cardiology 55th Annual Scientific Session
BJCardio editorial team
No content available
For healthcare professionals only
